Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naroa Serna

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Nanoscale|May 3, 2017
Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticlesMireia Pesarrodona, Eva Crosas, Rafael Cubarsi, et al.
ACS Applied Materials & Interfaces|June 15, 2021
Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent MaterialsLaura Sánchez-García, Eric Voltà-Durán, Eloi Parladé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 18, 2021
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, et al.
Nanomedicine (London, England)|January 18, 2018
Protein nanoparticles are nontoxic, tuneable cell stressorsMarianna Teixeira de Pinho Favaro, Laura Sánchez-García, Alejandro Sánchez-Chardi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 20, 2018
Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptidesMarianna Teixeira de Pinho Favaro, Naroa Serna, Laura Sánchez-García, et al.
Acta Biomaterialia|October 27, 2018
Assembly of histidine-rich protein materials controlled through divalent cationsHèctor López-Laguna, Ugutz Unzueta, Oscar Conchillo-Solé, et al.
Journal of Hematology & Oncology|April 17, 2020
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia disseminationVictor Pallarès, Ugutz Unzueta, Aïda Falgàs, et al.
Drug Delivery|May 9, 2022
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastasesRita Sala, Elisa Rioja-Blanco, Naroa Serna, et al.
Acta Biomaterialia|November 15, 2020
Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticlesEric Voltà-Durán, Naroa Serna, Laura Sánchez-García, et al.
Pharmaceutics|April 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse ModelElisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nanoscale|May 3, 2017
Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticlesMireia Pesarrodona, Eva Crosas, Rafael Cubarsi, et al.
ACS Applied Materials & Interfaces|June 15, 2021
Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent MaterialsLaura Sánchez-García, Eric Voltà-Durán, Eloi Parladé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 18, 2021
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, et al.
Nanomedicine (London, England)|January 18, 2018
Protein nanoparticles are nontoxic, tuneable cell stressorsMarianna Teixeira de Pinho Favaro, Laura Sánchez-García, Alejandro Sánchez-Chardi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 20, 2018
Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptidesMarianna Teixeira de Pinho Favaro, Naroa Serna, Laura Sánchez-García, et al.
Acta Biomaterialia|October 27, 2018
Assembly of histidine-rich protein materials controlled through divalent cationsHèctor López-Laguna, Ugutz Unzueta, Oscar Conchillo-Solé, et al.
Journal of Hematology & Oncology|April 17, 2020
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia disseminationVictor Pallarès, Ugutz Unzueta, Aïda Falgàs, et al.
Drug Delivery|May 9, 2022
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastasesRita Sala, Elisa Rioja-Blanco, Naroa Serna, et al.
Acta Biomaterialia|November 15, 2020
Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticlesEric Voltà-Durán, Naroa Serna, Laura Sánchez-García, et al.
Pharmaceutics|April 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse ModelElisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, et al.
Pageof 6